Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.72 |
| ▸ | GAA | P10253 | 2/20 | 0.72 |
| ▸ | MEN1 | O00255 | 4/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.68 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | HTT | P42858 | 1/20 | 0.64 |
| ▸ | PKM | P14618 | 1/20 | 0.62 |
| ▸ | PKLR | P30613 | 7/20 | 0.60 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.60 |
| ▸ | GFER | P55789 | 1/20 | 0.59 |
| ▸ | FABP1 | P07148 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2702246 | 0.88 | ALDH1A1 (0.76) | ALDH1A1GAAMEN1KMT2ATP53 | |
| SCHEMBL30708093 | 0.88 | ALDH1A1 (0.76) | ALDH1A1GAAMEN1KMT2ATP53 | |
| SCHEMBL18753536 | 0.85 | ALDH1A1 (0.78) | ALDH1A1GAAMEN1KMT2ATP53 | |
| SCHEMBL808364 | 0.84 | ALDH1A1 (1.00) | ALDH1A1GAAMEN1KMT2ATP53 | |
| SCHEMBL15480551 | 0.84 | MEN1 (0.73) | ALDH1A1GAAMEN1KMT2ATP53 | |
| SCHEMBL17210223 | 0.82 | ALDH1A1 (1.00) | ALDH1A1GAAMEN1KMT2ATP53 | |
| SCHEMBL10192086 | 0.81 | MEN1 (0.75) | ALDH1A1GAAMEN1KMT2ATP53 | |
| SCHEMBL22394150 | 0.81 | PKLR (0.82) | PKMPKLR | |
| SCHEMBL2702840 | 0.80 | PKLR (0.79) | PKMPKLR | |
| SCHEMBL3555597 | 0.80 | FABP1 (0.74) | ALDH1A1GAAMEN1KMT2ATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014074848-A1 | THERAPEUTIC COMPOUNDS AND COMPOSITIONS AND THEIR USE AS PKM2 MODULATORS | AGIOS PHARMACEUTICALS, INC. (US) | 2014-05-15 | — | — | WO | disclosed |